Clear-Cut Medical
Stage
Series B | AliveAbout Clear-Cut Medical
Clear-Cut Medical, founded in 2010, is a medical device company dedicated to improving the quality of care for cancer patients through its novel intra-operative MRI technology. The company has developed the compact, mobile, affordable and easy to use ClearSight system for excised tissue assessment. The system utilizes state of the art MRI protocols for tissue margin assessment, for example for the excised tissue in breast conserving surgery, to support real-time surgical decisions on the need for additional excision.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Clear-Cut Medical Patents
Clear-Cut Medical has filed 6 patents.
The 3 most popular patent topics include:
- Spectroscopy
- Medical imaging
- Nuclear magnetic resonance
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
8/2/2018 | 6/8/2021 | Surgical removal procedures, Nuclear magnetic resonance, Microscopy, Medical imaging, Spectroscopy | Grant |
Application Date | 8/2/2018 |
|---|---|
Grant Date | 6/8/2021 |
Title | |
Related Topics | Surgical removal procedures, Nuclear magnetic resonance, Microscopy, Medical imaging, Spectroscopy |
Status | Grant |
Latest Clear-Cut Medical News
May 31, 2015
Published On May 31, 2015 | Clear-Cut Medical , a Rehovot, Israel-based medical device company, has completed a Series B financing of undisclosed amount. The round was led by Previz Ventures. The company intends to use the funds for continued product development and commercialization of its novel ClearSightTM MRI system for cancer surgery margin assessment, where first clinical trials are being conducted for breast conserving surgery. The funds will support clinical trials in the U.S., Europe and Israel as well as global market development for the launch of the product in early 2016 and further product development. Led by Eyal Kolka, CEO, Clear-Cut Medical develops the ClearSightTM system, a compact and mobile MRI system for intra-operative margin assessment of excised tissue. It utilizes Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) protocols, which have shown effective results in tissue characterization in general and particularly in breast imaging. The company will pursue additional applications of the technology for prostate, thyroid and skin cancer surgery, as well as imaging of biopsy cores, providing the benefits of MRI in a mobile format that does not require special shielded suites. FinSMEs
Clear-Cut Medical Frequently Asked Questions (FAQ)
Where is Clear-Cut Medical's headquarters?
Clear-Cut Medical's headquarters is located at 10 Plaut st., Rehovot.
What is Clear-Cut Medical's latest funding round?
Clear-Cut Medical's latest funding round is Series B.
Who are the investors of Clear-Cut Medical?
Investors of Clear-Cut Medical include Previz Ventures.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
